Press Releases

Active Biotech has received an indicative bid for the property in Lund - the Board is positive
February 1, 2019 16:15 (CET)
Regulatory
Active Biotech provides updated information about the company's financial position
December 10, 2018 12:30 (CET)
Regulatory
Active Biotech's election committee appointed
November 19, 2018 08:30 (CET)
Active Biotech AB - Interim report January - September 2018
November 14, 2018 21:30 (CET)
Regulatory
Active Biotech: New data from the Phase 2 LEGATO-HD study will be presented at HSG 2018
November 8, 2018 13:00 (CET)
Active Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Huntington's Disease Network (EHDN) plenary meeting 2018"
September 13, 2018 11:00 (CEST)
Active Biotech regains global rights to development and commercialization of laquinimod
September 5, 2018 08:30 (CEST)
Regulatory
Active Biotech AB - Interim Report January - June 2018
August 9, 2018 08:30 (CEST)
Regulatory
Active Biotech provides update on laquinimod in Huntington's disease
July 31, 2018 09:15 (CEST)
Regulatory
Number of shares and votes in Active Biotech
May 31, 2018 08:30 (CEST)
Regulatory